mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.03 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.03 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.03 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.03 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.03 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.03 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.03 |